Qingcui Zou

2PUBLICATIONS
27CO-AUTHORS
NanomedicineNanotoxicology, health and safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Sep 30, 2026
A highly potent bispecific antibody confers complete protection against SFTSV in preclinical models.

|Nov 19, 2025
A rationally designed cocktail of nanobodies elicited by heterologous vaccination confers protection against SFTSV in preclinical models.

Xilin Wu, Linjing Zhu, Shengjian Liang

Pageof 1

Frequent Collaborators

1 joint publications

Xilin Wu

1 joint publications

Linjing Zhu

1 joint publications

Shengjian Liang

1 joint publications

Yaxin Wang